On 16 October 2020, Move to South Australia has announced that South Australia 2020/2021 skilled & Business Migration Program will be re-open until late November. An exact date is not known at the moment.  

Move to South Australia was originally planning to open Skilled & Business Migration Program in the mid of the October 2020, after the Federal Migration Budget 2020 announcement.

On 06 October 2020, Australian government has handed down the federal budget 2020 which is to recover the Australian economy.  2020/2021 migration planning level has also been released shortly after the federal budget announcement.  

____________________________________________________________________________

Highlights

• Australia’s net Migration remain the same
• Global Talent Independent Program (GTI) allocations have been tripled
• Business Innovation and Investment Program (BIIP) allocations have been doubled

_____________________________________________________________________________

Business & Skilled Migration Queensland Australia (BSMQ) has announced it will temporarily open statement nomination program (BSMQ business and skilled program) from Tuesday 29 September 2020 until Monday 5 October 2020.

BSMQ indicates the following:  

• They will only pick up NEW EOIs lodged from Tuesday 29 September 2020.
• The invitation will be closed if all supporting documents have not been uploaded in 24 hours.

The Australian immigration department has recently offered COVID-19 concessions to international students for Subclass 485 Temporary Graduate. During COVID-19 pandemic, many visa applicants and international students have been adversely affected by circumstances beyond their control, including Border closures, stand-downs and disruptions to courses.

The COVID-19 concessions are designed to ensure provisional and temporary visa holders are not disadvantaged by circumstances beyond their control during COVID-19 Pandemic, including Border closures, restrictions imposed on businesses and the general economic downturn related to COVID-19.